Connect with us

Health

People are Choosing Drug Discount Card to Save Money on the Prescribed Drugs

mm

Published

on

A global survey has found that people have been largely going for drug discount card in order to save money on the prescribed drugs. The rising prices of the drugs have contributed to increasing the awareness and hence the demand for drug discount card. With the use of drug discount card, it becomes possible for people to reduce their monthly expenses on drugs. Moreover, the drug sellers also use the drug discount card for their benefit because it helps them to increase their sales and build stronger brand loyalty.

And over the last few years, RX24 drugs has been offering drug coupons to help people cut their drug prices. This entity has not only just been able to make its name in the US but it has also managed to spread the word about its coupon to many other popular nations. According to the survey, about 90% of adults older than 65 believe in taking prescription medicine. 75% of people between 50-64 years go for prescribed drugs. And when it comes to people of age group, 18-29, the percentage of people taking prescribed drugs is 38%. In comparison to the younger people, the number of adults taking prescribed drugs is more. In the US, the demand for drug discount card is increasing among adults for these drug coupons are approved by health organisations such as FDA, HealthCare.gov, and Centers for disease control and prevention (CDC). 

About 70% of adults ask for the safety and potential side effects of a new drug on getting prescription from their doctor. Out of the total number of people taking medications, 40% adults ask for a less expensive alternative. The growing demand for drug discount cards is prevalent among the uninsured people who find it difficult to pay for the prescribed drugs due to budget constraints. People of the US and other countries have been supporting drug discount cards as these drug coupon cards help to remove the extra burden of drug prices to some extent. A discount of about 10-20% helps to reduce the drug costs from the shoulders of adult people which is simply making the concept of drug discount cards popular in various corners of the world.

As per the survey details, Americans spend an average of near $900 per year on prescriptions, which is more than other industrialised nations of the world. The reason of the high prices of drugs is simply due to the fact that companies don’t set any limit on the prices of drugs. On inventing a drug, a pharma company gains rights to sell that drug at the price a patient is willing to pay. And there is no facility for bargain on these fixed prices of drugs and hence this is where drug discount programs come handy. These programs only negotiate with the drug stores and skip the companies who make the drugs.

The drug stores accept the offer to sell the drugs at a lower price because they get more business for their stores. All the uninsured people flock to these drug stores in order to buy drugs for them. And it eventually contributes to increasing the brand loyalty of drug stores on a large scale.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

The Most Compatible Solution to the Human Body from Turkish Scientists for Joint Pains Warned by The World Health Organization!

mm

Published

on

Degeneration of the joints significantly complicates daily life.

The World Health Organization (WHO) predicts that by 2050, 130 million people worldwide will suffer from joint pain and osteoarthritis. According to the World Health Organization, by 2050, 40 million people will lose function due to osteoarthritis.

The USA is the country with the highest prevalence of osteoarthritis in the world. More than half (18.7 million people) of adults with osteoarthritis in the United States are of working age (18-64 years). For this reason, osteoarthritis also causes a significant loss of workforce.

Against joint pain and osteoarthritis Scientists have made an important discovery. Developed with hybrid technology, HYDRAVIC received full marks from health authorities.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.

IMPORTANT INVENTION FROM SCIENTISTS

Against joint pain and osteoarthritis, which the world is looking for a cure for, scientists have made an innovative development in intra-articular fluids. Turkish scientists have developed an intra-articular injection with the most compatible gel form with the hybrid production technology. The product, which was launched under the HYDRAVIC brand, attracts great attention all over the world.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.

HYDRAVIC IS VERY CLOSE TO THE HYALURONIC ACID STRUCTURE IN THE BODY

HYDRAVIC, one of the first intra-articular injections with hybrid production technology in Turkey, stands out with its patient satisfaction. Stating that HYDRAVIC minimizes the wear on the cartilage and slows down the pressure created by the body on the cartilage, Prof. Dr. Serdar Sezer said, “HYDRAVIC was developed with inspiration from the complex structure of hyaluronic acid in the body. Patient satisfaction is quite good. Hybrid technology is a system that has been applied for the first time in Turkey, like its examples in the world. HYDRAVIC prevents patients from complaining of pain for up to 6-8 months.” 

WHAT MAKES HYDRAVIC DIFFERENT IS THE DIFFERENCE OF ITS TECHNOLOGY!

Drawing attention to the importance of hybrid technology used in the production of HYDRAVIC, Professor Serdar Sezer “One of the features of hybrid technology is that it creates a triggering effect for the product to produce hyaluronic acid while being excreted from the body. This has been demonstrated in in-vitro and in-vivo experiments. Clinical long-term responses are very good. In our studies while developing these products, we have observed studies that have a longer duration of action with our innovative approach that repeats the results proven in the world. After its effectiveness has been proven, we are happy to introduce such a product to the market in the injection market, where we are one of the leading manufacturers in the field. We apply similar approaches across all our product models.” uses expressions.

Stating that they minimize the pain experienced by the patients during the injection, Professor Sezer said, “What makes HYDRAVIC different from other products is its technology. It is a product that does not make the patient feel very low or no pain during the injection and relieves the patient’s pain in a short time. In this technology, in addition to the molecular interaction, post-injection pain and swelling, etc., due to the production of the product in aseptic technical infrastructure. We minimize such complaints as possible.”

EUROPE’S LARGEST MEDICINE AND MEDICAL DEVICE R&D CENTER IS ESTABLISHED

Stating that Europe’s largest pharmaceutical and medical device R&D Center in the field of biomaterials was established in Turkey, Professor Sezer said, “To produce these kinds of products, the well-equipped infrastructures are required very serious costs. Many companies do not want to invest in such product groups, which have high infrastructure costs and are difficult to produce. With the new legislation, the costs increase significantly. We reach an annual capacity of 5.4 million units in 2023 in the HYDRAVIC production line, where we have achieved great success in the medical market.” he said.

Continue Reading

Trending